About Knovea
Knovea is a Healthcare company. Pharmaceutical manufacturing, RD, and quality services in India. The company has 115 employees. Its Indian entity Knovea Pharmaceutical Private Limited reported revenue of ₹62.7 Lakh. Knovea offers products and services including Sterile Pharmaceutical Formulations and Research and Development Services. Its focus areas include Pharmaceuticals, Manufacturing, Sterile Formulations and Research and Development.
Company details
Knovea is involved in pharmaceutical manufacturing and RD, focusing on sterile formulations and innovative delivery systems that are supported by aseptic technologies and electronic records. Established since 2004, adherence to cGMP standards and regulatory compliance is maintained to ensure products meet international quality norms. Investments in infrastructure are made to enhance affordability of medicines, while a commitment to quality, quantity, and safety is upheld through streamlined GxP processes. Collective growth is fostered by embracing expertise and nurturing teams, contributing to a healthier future.
- Employees 115
- SectorsHealthcare
- Email••••••••
- Legal Name Knovea Pharmaceutical Pvt. Limited
- Date of Incorporation 17 Feb, 2020
- Jurisdiction Indore, Madhya Pradesh, India
- Indian entity revenue₹62.7 Lakh
FY 2025 · +321% YoY
- Indian entity net loss-₹13.81 Cr
FY 2025 · -2203% margin
- Indian entity EBITDA-₹9.98 Cr
FY 2025 · -1592% margin
- Employee Count115
Associated legal entities of Knovea
Knovea operates through Knovea Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Knovea Pharmaceutical Private Limited CIN U24110MP2020PTC050978 | Active | 17 Feb 2020 | Indore, Madhya Pradesh | ₹0.6 Cr | 115 | 3 | View details |
Products & Services of Knovea
Knovea offers a comprehensive portfolio of products and services, including Sterile Pharmaceutical Formulations and Research and Development Services.
Sterile pharmaceutical finished dosage forms are developed and commercialized from initial stages to market readiness
Innovation in pharmaceuticals is driven through advanced research, technology, and expertise in R&D technical services
Board of directors of Knovea Pharmaceutical Private Limited (Knovea)
Knovea Pharmaceutical Private Limited is the primary company behind Knovea. The board of Knovea Pharmaceutical Private Limited currently have 3 directors; the longest-serving is Anil Satwani, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Satwani DIN 00041531 | Director | 17 Feb 2020 | 6 yrs 8 mo | Knovea Pharmaceutical Private Limited |
| Rohit Brijmohan Mantri DIN 07435803 | Nominee Director | 17 Feb 2020 | 6 yrs 8 mo | Knovea Pharmaceutical Private Limited |
| Buggana Hariharnath DIN 00695002 | Nominee Director | 16 Sep 2024 | 2 yrs 1 mo | Knovea Pharmaceutical Private Limited |
Financials of Knovea
Figures of Knovea Pharmaceutical Private Limited, the primary company behind Knovea, for FY 2025. Revenue was ₹62.7 Lakh (+321% year on year). Net loss was -₹13.81 Cr (-2203% margin). EBITDA was -₹9.98 Cr (-1592% margin). Revenue has grown at a compounded annual rate of -77% over three years.
- ₹62.7 LakhRevenue · FY 2025 · +321% YoY
- -₹13.81 CrNet loss · -2203% margin
- -₹9.98 CrEBITDA · -1592% margin
- ₹1.00 CrPaid-up capital
- 115Employees (provident fund records)
- -77%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Knovea Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Knovea
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Knovea
Knovea has 115 employees.
The primary company behind Knovea, Knovea Pharmaceutical Private Limited, reported revenue of ₹62.7 Lakh for FY 2025, up 321% year on year.
Knovea is involved in pharmaceutical manufacturing and RD, focusing on sterile formulations and innovative delivery systems that are supported by aseptic technologies and electronic records. Established since 2004, adherence to cGMP standards and regulatory compliance is maintained to ensure products meet international quality norms. Investments in infrastructure are made to enhance affordability of medicines, while a commitment to quality, quantity, and safety is upheld through streamlined GxP processes. Collective growth is fostered by embracing expertise and nurturing teams, contributing to a healthier future.
Knovea offers Sterile Pharmaceutical Formulations and Research and Development Services.
Knovea operates through Knovea Pharmaceutical Private Limited.
The legal entities of Knovea currently have 3 directors, including Anil Satwani, Rohit Brijmohan Mantri, Buggana Hariharnath.